Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Aynur Daglar"'
Autor:
Fehmi Hindilerden, Özge Nuran Akay, Elif Aksoy, Aynur Daglar Aday, Emine Gültürk, Meliha Nalçacı, İpek Yönal Hindilerden
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 4, Pp 246-255 (2024)
Objective: We investigated the occurrence and characteristics of secondary solid cancers (SSCs) in patients with Philadelphia chromosome-negative myeloproliferative neoplasms (Ph- MPNs) from Türkiye. We identified the potential risk factors for SSC
Externí odkaz:
https://doaj.org/article/9fb7d1ed5b794bd3a7801fc7d8977dd3
Autor:
Fehmi Hindilerden, Özge Nuran Akay, Elif Aksoy, Aynur Daglar Aday, Emine Gültürk, Meliha Nalçacı, İpek Yönal Hindilerden
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 2-3 (2024)
Objective: Philadelphia chromosome-negative myeloproliferative neoplasms (Ph- MPNs) are characterized by clonal myeloproliferation and somatic mutations. Major complications of Ph-MPNs are thrombosis, bleeding, transformation to myelofibrosis and leu
Externí odkaz:
https://doaj.org/article/31af40f7c73d4937be3657f709e111a7
Autor:
Hasan Dermenci, Aynur Daglar Aday, Aysegul Basak Akadam Teker, Veysel Sabri Hancer, Metin Yusuf Gelmez, Meliha Nalcaci, Akif Selim Yavuz
Publikováno v:
Haseki Tıp Bülteni, Vol 60, Iss 3, Pp 228-233 (2022)
Aim:Activation-induced cytidine deaminase (AID) has been associated with tumor initiation and development because of its ability to generate DNA damage and somatic mutations that cause genomic instability. This study aimed to investigate the relation
Externí odkaz:
https://doaj.org/article/51c97b5cd8d84948b39312348cbf8d19
Autor:
Dermenci, Hasan1, Aday, Aynur Daglar2 aynur.aday@istanbul.edu.tr, Akadam Teker, Aysegul Basak3, Hancer, Veysel Sabri4, Gelmez, Metin Yusuf5, Nalcaci, Meliha6, Yavuz, Akif Selim6
Publikováno v:
Medical Bulletin of Haseki / Haseki Tip Bulteni. May2022, Vol. 60 Issue 3, p228-233. 6p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Betul Bozkurt Bulakcı, Aynur Daglar Aday, Basak Gurtekin, Akif Selim Yavuz, Sukru Ozturk, Kivanc Cefle, Ayse Palanduz, Sukru Palanduz
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 38:668-674
The introduction of tyrosine kinase inhibitors (TKI) has resulted in a significant improvement in the treatment of CML patients. However, some CML patients are resistant to imatinib therapy, the initial TKI therapy in the CML. Therefore, it is import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d22dd68a59fbdafd08f971e2c4d7202d
https://doi.org/10.1007/s12288-022-01532-2
https://doi.org/10.1007/s12288-022-01532-2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Experimed; Aug2023, Vol. 13 Issue 2, p103-108, 6p
Autor:
Aynur Daglar Aday, Figen Aksoy, Başak Akadam Teker, Turgay Isbir, Tülin Öztürk, Oğuz Öztürk, Hülya Yılmaz Aydoğan
Publikováno v:
Turkish Journal of Biochemistry. 46:455-460
Objectives CYP2D6 is highly polymorphic and a common variant CYP2D6*4 results in the generation of poor metabolizer enzyme. The CYP2D6*4 variant has been associated with altered susceptibility to several cancers. The aim of the present case-control s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::224a70e9e4a600dbc235ca736a3a1ab2
https://doi.org/10.1515/tjb-2020-0103
https://doi.org/10.1515/tjb-2020-0103